Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 5Colonic Neoplasms 5Pancreatic Neoplasms 3Osteosarcoma 3Melanoma 3Medulloblastoma 3Glioblastoma 3Familial ependymoma 3Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Astrocytoma 2Wilms Tumor 1Vipoma 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1

Interventions

trifluridine tipiracil drug combination 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Oxaliplatin × CNS × Clear all
NCT05919264 2026-05-28

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡